Literature DB >> 2770118

Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy.

A W van den Wall Bake1, M R Daha, J J Haaijman, J Radl, A van der Ark, L A van Es.   

Abstract

In bone marrow cultures of 15 patients with primary IgA nephropathy we found significantly (P = 0.02) increased synthesis of both monomeric and polymeric IgA1 compared to 23 controls, by using high performance liquid chromatography (HPLC) fractionation of culture supernatants. The relative contribution of polymeric to total IgA1 produced was not different for the two groups. Two-color immunofluorescence studies of the percentage of bone marrow IgA1 plasma cells able to bind secretory component in vitro showed no difference between patients and controls. In the sera of patients with primary IgA nephropathy the relative contribution of IgA1 polymers to total IgA1 was also similar to controls. These results indicate that in IgA nephropathy, the increased IgA production in the bone marrow is restricted to the IgA1 subclass. The production of both monomeric and polymeric IgA1 is increased in patients during a quiescent phase of the disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2770118     DOI: 10.1038/ki.1989.139

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.

Authors:  L-X Xu; Y Yan; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

Review 2.  Pathogenesis of IgA nephropathy.

Authors:  Kar Neng Lai
Journal:  Nat Rev Nephrol       Date:  2012-03-20       Impact factor: 28.314

3.  Increased IL-10 production by stimulated whole blood cultures in primary IgA nephropathy.

Authors:  J W De Fijter; M R Daha; W E Schroeijers; L A van Es; C Van Kooten
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

4.  IgA nephropathy and idiopathic thrombocytopenic purpura with splenectomy: a case report.

Authors:  M Morino; K Inami; A Shibuya; N Sasaki
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

5.  Enhanced expression of L-selectin on peripheral blood lymphocytes from patients with IgA nephropathy.

Authors:  A Kennel-de March; M C Bene; E Renoult; M Kessler; G C Faure; M N Kolopp-Sarda
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

6.  Pathogenic role of polyclonal and polymeric IgA in a murine model of mesangial proliferative glomerulonephritis with IgA deposition.

Authors:  E Muso; H Yoshida; E Takeuchi; T Shimada; M Yashiro; T Sugiyama; C Kawai
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

7.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

8.  IgA and IgG immune complexes increase human macrophage C3 biosynthesis.

Authors:  J Laufer; H Boichis; N Farzam; J H Passwell
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

9.  Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy.

Authors:  Y Yan; L-X Xu; J-J Zhang; Y Zhang; M-H Zhao
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

Review 10.  Molecular heterogeneity of human IgA antibodies during an immune response.

Authors:  M W Russell; C Lue; A W van den Wall Bake; Z Moldoveanu; J Mestecky
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.